Surgery Websites
Resident Portal »  Current Residents »  Jeremy M. Sharib, M.D.
Jeremy M. Sharib, M.D.

Jeremy M. Sharib, M.D.

Chief Resident (PGY-5)
General Surgery 

Contact Information

Open Popup
  • University of Rochester, 2007 BS Biomedical Engineering, 2007, Certificate of Management Studies
  • University of California Irvine, 2013 MD
  • University of California San Francisco Medical Center - General Surgery Intern - 2013-2014
  • University of California San Francisco Medical Center - General Surgery Resident - 2014-present
  • Surgical Oncology
  • Pancreatic Cysts
  • Pancreatic Cancer
  • Pancreatic Cancer
  • IPMN
  • Pancreatic Cysts
Jeremy M. Sharib, M.D. is a General Surgery Resident at the UCSF Department of Surgery. He completed two years of research in the department of Pharmaceutical Chemistry under the mentorship of Dr. Kimberly Kirkwood and Dr. Charles Craik. His work aimed to understand the role of protease dysregulation in mucinous pancreatic cysts and pancreatic cancer. He is also interested in discovering genetic and protease activity based biomarkers for potentially malignant cysts. Dr. Sharib's clinical interest, similarly, is to improve diagnosis and management of IPMN, a type of Pancreatic Cyst. Following General Surgery training, Dr. Sharib plans to complete a fellowship in Surgical Oncology.
Resident shown in bold. Research Mentor(s) shown in GREEN.
Publications provided by UCSF Profiles, powered by CTSI at UCSF.
  1. Moroz A, Wang YH, Sharib JM, Wei J, Zhao N, Huang Y, Chen Z, Martinko AJ, Zhou J, Lim SA, Zhang LH, Seo Y, Carlin S, Leung KK, Collisson EA, Kirkwood KS, Wells JA, Evans MJ. Theranostic targeting of CUB domain containing protein 1 (CDCP1) in pancreatic cancer. Clin Cancer Res. 2020 Apr 27. View in PubMed
  2. Cao CX, Sharib JM, Blanco AM, Goldberg D, Bracci P, Mukhtar RA, Esserman LJ, Kirkwood KS. Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study. J Am Coll Surg. 2020 Jan; 230(1):53-63.e1. View in PubMed
  3. Jeremy Sharib, Carrie Cao, Paige Bracci, Amie Blanco, Dena Goldberg, Laura Esserman, Kimberly Kirkwood. Abdominal Imaging Does Not Detect Higher Rates of Pancreatic Cysts or Cyst-Associated Pancreatic Adenocarcinoma in BRCA Mutation Carriers. . 2019 Oct 1; 229(4):s170. View in PubMed
  4. Jeremy Sharib, Carrie Cao, Paige Bracci, Amie Blanco, Dena Goldberg, Laura Esserman, Kimberly Kirkwood. Abdominal Imaging Does Not Detect Higher Rates of Pancreatic Cysts or Cyst-Associated Pancreatic Adenocarcinoma in BRCA Mutation Carriers. Journal of the American College of Surgeons. 2019 Oct 1; 229(4):s170. View in PubMed
  5. Wang MT, Fer N, Galeas J, Collisson EA, Kim SE, Sharib J, McCormick F. Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. Nat Commun. 2019 07 11; 10(1):3055. View in PubMed
  6. Ivry SL, Knudsen GM, Caiazza F, Sharib JM, Jaradeh K, Ravalin M, O'Donoghue AJ, Kirkwood KS, Craik CS. The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts. Biol Chem. 2019 11 26; 400(12):1629-1638. View in PubMed
  7. Jeremy Sharib, Kenneth Wimmer, Annabelle L. Fonseca, Yu Shen, Eugene J. Koay, Anirban Maitra, Laura Esserman, Elissa Ozanne, Kimberly S. Kirkwood. Sensitivity and Specificity Required for Diagnostics or Management Guidelines for Intraductal Papillary Mucinous Neoplasms to Be Cost-Effective. . 2018 Oct 1; 227(4):s180-s181. View in PubMed
  8. Jeremy Sharib, Kenneth Wimmer, Annabelle L. Fonseca, Yu Shen, Eugene J. Koay, Anirban Maitra, Laura Esserman, Elissa Ozanne, Kimberly S. Kirkwood. Sensitivity and Specificity Required for Diagnostics or Management Guidelines for Intraductal Papillary Mucinous Neoplasms to Be Cost-Effective. Journal of the American College of Surgeons. 2018 Oct 1; 227(4):s180-s181. View in PubMed
  9. Sharib JM, Fonseca AL, Swords DS, Jaradeh K, Bracci PM, Firpo MA, Hatcher S, Scaife CL, Wang H, Kim GE, Mulvihill SJ, Maitra A, Koay EJ, Kirkwood KS. Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making? Surgery. 2018 12; 164(6):1178-1184. View in PubMed
  10. Jeremy Sharib, Annabelle L. Fonseca, Grace E. Kim, Eugene J. Koay, Anirban Maitra, Kimberly S. Kirkwood. Which Clinical Features Predict Overtreatment for Intraductal Papillary Mucinous Neoplasms?. . 2017 Oct 1; 225(4):s140. View in PubMed
  11. View All Publications

 

Site Directory
    X